Effect of psoralen on TopoIIα expression in breast cancer stem cells
10.7652/jdyxb201705025
- VernacularTitle:补骨脂素对乳腺癌干细胞拓扑异构酶Ⅱα表达的影响
- Author:
Chengfeng XU
;
Xiaohong WANG
;
Yitong HUA
;
Kai CHENG
;
Weiwei ZOU
;
Jian LIU
;
Yingzhe ZHANG
;
Zhenlin YANG
- Keywords:
psoralen;
TopoⅡα;
drug resistance;
stem cell;
breast cancer
- From:
Journal of Xi'an Jiaotong University(Medical Sciences)
2017;38(5):744-748
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the effect of psoralen on topoisomerase IIα(TopoIIα) expression of breast cancer stem cells.Methods CD44+CD24-/low breast cancer stem cells were sorted from MCF-7/ADR by magnetic-activated cell sorting(MACS).We observed the growth characteristics of these stem cells through optical microscope and detected the growth-inhibitory effects of psoralen on breast cancer stem cells by CCK-8 assay and IC50 of adriamycin and adriamycin combined with psoralen to calculate the reversal index.The mRNA and protein expressions of Topo IIα were detected using RT-PCR and Western blot, respectively.Results Under the optical microscope, breast cancer stem cells presented spheres.IC10 and IC20 of psoralen on breast cancer stem cells were (6.77±0.23)μg/mL and (10.36±0.21)μg/mL.IC50 of adriamycin and adriamycin combined with psoralen on breast cancer stem cells was (90.03±3.56)μg/mL and (21.47±0.82)μg/mL, the reversal index was 4.19.Psoralen significantly raised the expressions of Topo Ⅱα at mRNA and protein levels.Conclusion Psoralen reversed the resistance of adriamycin by increasing the gene and protein expressions of breast cancer stem cells Topo Ⅱα and the drug targets.
